Vulnerable children offered COVID vaccine

Vulnerable children offered COVID vaccine

The Health and Social Care Secretary has accepted the advice of the Joint Committee on Vaccination and Immunisation to offer vaccines to vulnerable young people.

The JCVI has advised that children at increased risk of serious COVID-19 disease – including children aged 12 to 15 with severe neurodisabilities, Down’s syndrome, immunosuppression and multiple or severe learning disabilities - are offered the Pfizer-BioNTech vaccine.

The JCVI also recommends that children and young people aged 12 to 17 who live with an immunosuppressed person should be offered the vaccine. This is to indirectly protect their immunosuppressed household contacts, who are at higher risk of serious disease from COVID-19 and may not generate a full immune response to vaccination.

Young people aged 16 to 17 with underlying health conditions which put them at higher risk of serious COVID-19 should have already been offered vaccination.

Health and Social Care Secretary Sajid Javid said: “Today’s advice from the independent Joint Committee on Vaccination and Immunisation (JCVI) means more vulnerable young people at greatest risk from this virus can now benefit from COVID-19 vaccines. I have accepted their expert recommendations and I have asked the NHS to prepare to vaccinate those eligible as soon as possible.

“Young people aged 12 to 15 with severe neuro-disabilities, Down’s Syndrome, immunosuppression and multiple or severe learning disabilities, as well as people who are household contacts of individuals who are immunosuppressed, will be eligible for vaccination soon.

“Our independent medicines regulator, the Medicines and Healthcare products Regulatory Agency, has approved the Pfizer/BioNTech vaccine for people aged 12 and over as it meets their robust standards of safety, effectiveness and quality.

“Today’s advice does not recommend vaccinating under-18s without underlying health conditions at this point in time. But the JCVI will continue to review new data, and consider whether to recommend vaccinating under-18s without underlying health conditions at a future date.

“COVID-19 vaccines have saved almost 37,000 lives and prevented around 11.7 million infections in England alone. They are building a wall of defence and are the best way to protect people from serious illness. I encourage everybody who is eligible to get their jabs as soon as they can,” he added.

The Pfizer-BioNTech vaccine is the only vaccine that has been authorised for children aged 12 and older in the UK, following a US clinical trial in around 1,000 children aged 12 to 15.

The JCVI is not currently advising routine vaccination of children outside of these groups, based on the current evidence.

Delivering a diverse, reliable range of services to children and their families across the UK
D1, Parkside, Knowledge Gateway, Nesfield Road, Colchester, Essex CO4 3ZL
Tel: 01206 878178Contact Us

A Mackman Group collaboration - market research by Mackman Research | website design by Mackman